Clinuvel Pharmaceuticals Ltd
XMUN:UR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
Dividends
Dividend Yield
Clinuvel Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Clinuvel Pharmaceuticals Ltd
UR9 have increased by 339%.
Payout Ratio
Clinuvel Pharmaceuticals Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
UR9 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
UR9 Price
Clinuvel Pharmaceuticals Ltd
| Average Annual Return | -26.34% |
| Standard Deviation of Annual Returns | 1.59% |
| Max Drawdown | -81% |
| Market Capitalization | 414.7m EUR |
| Shares Outstanding | 150 923 010 |
| Percentage of Shares Shorted |
N/A
|
UR9 Return Decomposition
Main factors of price return
Stock Splits
UR9's latest stock split occurred on Nov 12, 2010
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
The adjusted shares began trading on Nov 12, 2010. This was the only stock split in UR9's history.